Smart insulin dosing system aims to simplify diabetes management
NCT ID NCT07681375
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study tests a system that combines a continuous glucose monitor (CGM) with daily insulin dose recommendations for people with type 2 diabetes who are starting basal insulin. Participants wear a Dexcom CGM sensor and receive suggested insulin doses through the DexBasal system, which a physician reviews. The goal is to see if the system is safe and works well for managing blood sugar levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Basal insulin (DexBasal)
What this could lead to
If successful, this system could help people with type 2 diabetes manage their blood sugar more easily and safely by automating insulin dose adjustments.
What could go wrong
This is a small, early-phase feasibility study, so the system may not work as intended or may not improve outcomes. Risks include low blood sugar (hypoglycemia) and device issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Short-term arm immobilization & muscle metabolis NCT06750497
- Omega-3 for Type 2 Diabetes & Heart Disease - NCT07677995
- Polypill Trial for Heart Risk in China (NCT07679828)
- Switching from Weekly to Monthly Diabetes Shot T NCT07677891
- Blood Flow Restriction Training in Type 2 Diabet NCT07676305
- HRS-7535 vs Dapagliflozin for Type 2 Diabetes (NCT06589765)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
San Diego Family Care (SDFC)
San Diego, California, 92111, United States